Back to search

France· FR:66864885

RISEDRONATE ARROW 35 mg, comprimé pelliculé

A medicinal product containing risédronate monosodique hémipentahydraté, registered in France by ARROW GENERIQUES, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRISEDRONATE ARROW 35 mg, comprimé pel…ATC—REGISTER NO.FR:66864885PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉ
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400921717631
    plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 4 comprimé(s)
    EUR 9.22
  • cip13
    3400921717921
    plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 12 comprimé(s)
    EUR 27.32

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Risédronate monosodique hémipentahydraté in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All risédronate monosodique hémipentahydraté products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Germany · Risedronat Al
  • Italy · Risedronato Eg Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5af753a4-3d97-4eea-8045-2df61e74cd4c
GET /v1/drugs/5af753a4-3d97-4eea-8045-2df61e74cd4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66864885",
  "date_amm": "2011-10-21",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about risédronate monosodique hémipentahydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.